Market Cap: $376.86M
EI
Enanta Pharmaceuticals, Inc.
ENTA
NASDAQ (NASDAQ Global Select)USD
Market Cap: $376.86M
Analysts estimated ENTA earnings of $-0.52 per share this quarter (Q3). ENTA's actual earnings were $-0.67 per share.
ENTA EPS surprise of -28.80%Analysts estimated ENTA earnings of $-0.52 per share this quarter (Q3). ENTA's actual earnings were $-0.67 per share.
ENTA EPS surprise of -28.80%Analysts estimated ENTA earnings of $-0.50 per share this quarter (Q2). ENTA's actual earnings were $-0.45 per share.
ENTA EPS surprise of 9.60%Analysts estimated ENTA earnings of $-0.82 per share this quarter (Q1). ENTA's actual earnings were $-0.42 per share.
ENTA EPS surprise of 49.01%Analysts estimated ENTA earnings of $-1.04 per share this quarter (Q4). ENTA's actual earnings were $-0.87 per share.
ENTA EPS surprise of 16.46%Analysts estimated ENTA earnings of $-1.30 per share this quarter (Q3). ENTA's actual earnings were $-0.85 per share.
ENTA EPS surprise of 34.72%Analysts estimated ENTA earnings of $-1.16 per share this quarter (Q2). ENTA's actual earnings were $-1.06 per share.
ENTA EPS surprise of 8.52%Analysts estimated ENTA earnings of $-1.38 per share this quarter (Q1). ENTA's actual earnings were $-1.05 per share.
ENTA EPS surprise of 23.90%Analysts estimated ENTA earnings of $-1.18 per share this quarter (Q4). ENTA's actual earnings were $-1.36 per share.
ENTA EPS surprise of -14.94%Analysts estimated ENTA earnings of $-1.48 per share this quarter (Q3). ENTA's actual earnings were $-1.07 per share.
ENTA EPS surprise of 27.64%Analysts estimated ENTA earnings of $-1.32 per share this quarter (Q2). ENTA's actual earnings were $-1.47 per share.
ENTA EPS surprise of -11.00%Analysts estimated ENTA earnings of $-1.22 per share this quarter (Q1). ENTA's actual earnings were $-1.58 per share.
ENTA EPS surprise of 29.73%